← Back to headlines
Eli Lilly's Retatrutide Shows Strong Phase 3 Trial Results
CNBC reports that Eli Lilly has announced robust Phase 3 trial results for its drug Retatrutide, indicating promising efficacy.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Japan Household Spending Drops 3.6% in July for Eighth Consecutive Month
20m ago
US Probes Deadly Strike on Iranian Wedding Linked to American Munitions
32m ago
Volkswagen Approves Plan to Cut 100,000 Jobs and Halve Vehicle Lineup
35m ago
Trump Administration Asks Supreme Court to Allow Mail-In Voting Restrictions
36m ago